Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Alpine Immune Sciences Inc shares valued at $2,745,830 were sold by Rickey James Paul on Jan 26 ’24. At $23.32 per share, Rickey James Paul sold 117,764 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Rickey James Paul sold 236 shares, netting a total of over 5,192 in proceeds. Following the sale of shares at $22.00 each, the insider now holds 0 shares.
Before that, ORBIMED ADVISORS LLC had sold 1,364,849 shares from its account. In a trade valued at $25,049,034, the Director traded Alpine Immune Sciences Inc shares for $18.35 each. Upon closing the transaction, the insider’s holdings decreased to 1,364,849 shares, worth approximately $17.07 million.
As published in their initiating research note from Guggenheim on April 09, 2024, Alpine Immune Sciences Inc [ALPN] has been a Buy and the price target has been revised to $55. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid February. As of October 18, 2023, Berenberg has initiated its “Buy” rating for ALPN. Earlier on October 17, 2023, Berenberg initiated its rating. Their recommendation was “a Buy” for ALPN stock.
Analyzing ALPN Stock Performance
During the last five days, there has been a surge of approximately 0.17%. Over the course of the year, Alpine Immune Sciences Inc shares have jumped approximately 238.77%. Shares of the company reached a 52-week high of $64.70 on 04/23/24 and a 52-week low of $17.32 on 01/05/24. A 50-day SMA is recorded $41.94, while a 200-day SMA reached $21.78. Nevertheless, trading volume fell to 1.18 million shares from 3.1 million shares the previous day.
Support And Resistance Levels for Alpine Immune Sciences Inc (ALPN)
According to the 24-hour chart, there is a support level at 64.54, which, if violated, would cause prices to drop to 64.52. In the upper region, resistance lies at 64.61. The next price resistance is at 64.66. RSI (Relative Strength Index) is 83.41 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 7.12, which suggests the price will increase in the coming days. Percent R is at 0.43%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
